S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(0.46%) $78.47
Gas
(0.70%) $2.16
Gold
(0.68%) $2 324.20
Silver
(1.92%) $27.20
Platinum
(-0.38%) $961.60
USD/EUR
(-0.03%) $0.929
USD/NOK
(-0.17%) $10.86
USD/GBP
(-0.05%) $0.797
USD/RUB
(0.00%) $91.45

实时更新: Xenetic Biosciences Inc [XBIO]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
Upcoming Earnings Alert

3 days till quarter result
(bmo 2024-05-09)

Expected move: +/- 10.79%

最后更新时间4 May 2024 @ 04:00

10.34% $ 4.27

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):
Profile picture for Xenetic Biosciences Inc

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens...

Stats
今日成交量 5 712.00
平均成交量 5 490.00
市值 6.58M
EPS $0 ( 2024-03-28 )
下一个收益日期 ( $-0.790 ) 2024-05-09
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.580
ATR14 $0.122 (2.86%)
Insider Trading
Date Person Action Amount type
2023-12-06 Mizrahy Moshe Buy 2 500 Stock Options
2023-12-06 Mizrahy Moshe Sell 0 Common Stock
2023-12-11 Lockshin Curtis Buy 10 000 Stock Options
2023-12-11 Eisenberg Jeffrey F Buy 20 000 Stock Options
2023-12-11 Parslow James F Buy 10 000 Stock Options
INSIDER POWER
100.00
Last 95 transactions
Buy: 3 350 890 | Sell: 1 809 302

Xenetic Biosciences Inc 相关性

10 最正相关
HNNA0.854
APOP0.847
MDRR0.841
MBIO0.836
YTEN0.834
ISNS0.826
NCTY0.821
JAKK0.819
NXTC0.812
PRPO0.809
10 最负相关
BOCH-0.805

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Xenetic Biosciences Inc 财务报表

Annual 2023
营收: $2.54M
毛利润: $2.54M (100.00 %)
EPS: $-2.71
FY 2023
营收: $2.54M
毛利润: $2.54M (100.00 %)
EPS: $-2.71
FY 2022
营收: $1.71M
毛利润: $1.68M (98.42 %)
EPS: $-4.49
FY 2021
营收: $1.16M
毛利润: $0.00 (0.00 %)
EPS: $-0.883

Financial Reports:

No articles found.

Xenetic Biosciences Inc

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. It is also leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。